image
UroGen Pharma Ltd. URGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 11.19
-5.65 %
$ 472 M
Market Cap
-3.79
P/E
BALANCE SHEET
178 M ASSETS
30.88%
Growth Rates
1Year 30.88%
3Years 13.48%
5Years 11.48%
7Years 33.94%
10Years 49.37%
244 M LIABILITIES
8.24%
Growth Rates
1Year 8.24%
3Years 111.75%
5Years 78.43%
7Years 66.91%
10Years 86.28%
-65.2 M EQUITY
26.51%
Growth Rates
1Year 26.51%
3Years -18.80%
5Years -11.51%
7Years -25.85%
10Years -37.86%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition UroGen Pharma Ltd.
image
Current Assets 169 M
Cash & Short-Term Investments 137 M
Receivables 15.4 M
Other Current Assets 16.8 M
Non-Current Assets 9.12 M
Long-Term Investments 4.73 M
PP&E 2.36 M
Other Non-Current Assets 2.04 M
Current Liabilities 31.2 M
Accounts Payable 6.51 M
Short-Term Debt 819 K
Other Current Liabilities 23.9 M
Non-Current Liabilities 212 M
Long-Term Debt 99.4 M
Other Non-Current Liabilities 113 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 95.0 55.4 44.4 103.9 49.7 101.3 37.0 21.4 18.0 3.9 3.0
Short Term Investments 42.0 44.6 44.8 49.2 97.4 0 36.0 0 0 0 0
Receivables 15.4 12.7 11.7 7.0 0 0 0 83 K 0 0 0
Inventory 5.7 4.3 4.8 2.0 0 0 0.3 0.1 0 0 0
Other Current Assets 11.1 11.9 8.7 4.6 1.6 0.9 1.2 0.5 1.2 0.4 0.1
Total Current Assets 169.2 128.9 114.4 115.6 148.6 102.2 74.5 22.0 19.1 4.3 3.1
PP&E 2.4 3.7 3.1 4.2 4.7 0.9 0.8 0.7 0.3 71 K 77 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 4.7 0.2 0.7 1.9 48.6 51 K 29 K 24 K 0 0 0
Other Long Term Assets 2.0 2.7 1.5 0.3 0.5 0.3 0.2 0.2 0 0 0
Other Assets 0 0.6 0 0 0 0 0 0 0 0 0
Total Assets 178.3 136.2 119.7 122.0 202.4 103.6 75.5 23.1 19.4 4.4 3.2
LIABILITIES
Accounts Payable 6.5 5.5 5.8 3.3 4.7 4.3 2.8 1.9 1.7 0.5 0.3
Short Term Debt 0.8 0.9 0 0 0 0 0 0 0 0 0
Other Current Liabilities 23.9 17.4 16.6 18.2 14.8 9.2 3.5 1.3 0.5 0.4 0.1
Total Current Liabilities 31.2 23.9 22.4 21.4 19.5 13.5 7.0 3.1 2.2 0.9 0.5
Long Term Debt 99.4 99.1 0.4 1.5 2.6 0 0 0 0 0 0
Deferred Tax Income 0 3.0 2.8 2.7 0 0 0 0 0 0 0
Other Liabilities 112.9 101.9 88.6 2.7 0 0 0 3.6 0.9 0 0
Total Liabilities 243.5 225.0 111.3 25.6 22.1 13.5 7.0 6.7 3.1 0.9 0.5
EQUITY
Common Stock 89 K 63 K 61 K 60 K 57 K 44 K 37 K 6 K 6 K 2 K 2 K
Retained Earnings (679.3) (577.1) (467.3) (356.5) (228.0) (122.9) (47.2) (27.2) (25.3) (12.6) (8.1)
Other Accumulative Comprehensive Income/Loss 12 K (0.1) 25 K 0.3 0.3 (0.7) (0.6) (0.4) (0.2) 0 0
Total Equity (65.2) (88.7) 8.4 96.4 180.3 90.1 68.5 16.3 16.3 3.5 2.7
Total Liabilities and Equity 178.3 136.2 119.7 122.0 202.4 103.6 75.5 23.1 19.4 4.4 3.2
SHARES OUTSTANDING
Common Shares Outstanding 28.8 22.8 22.3 21.8 20.5 15.8 9.7 12.0 2.3 2.3 2.1